You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Cephapirin sodium - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for cephapirin sodium and what is the scope of patent protection?

Cephapirin sodium is the generic ingredient in two branded drugs marketed by Apothecon, Abraxis Pharm, and Hikma, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for cephapirin sodium.

Recent Clinical Trials for cephapirin sodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Federal University of São PauloPhase 4
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4

See all cephapirin sodium clinical trials

Medical Subject Heading (MeSH) Categories for cephapirin sodium

US Patents and Regulatory Information for cephapirin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon CEFADYL cephapirin sodium INJECTABLE;INJECTION 050446-005 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abraxis Pharm CEPHAPIRIN SODIUM cephapirin sodium INJECTABLE;INJECTION 062723-001 Nov 17, 1986 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apothecon CEFADYL cephapirin sodium INJECTABLE;INJECTION 050446-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apothecon CEFADYL cephapirin sodium INJECTABLE;INJECTION 061769-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.